Home > Healthcare > Pharmaceuticals > Drug Delivery > Nicotine Replacement Therapy Market

Nicotine Replacement Therapy Market Size

  • Report ID: GMI7725
  • Published Date: Dec 2023
  • Report Format: PDF

Nicotine Replacement Therapy Market Size

Nicotine Replacement Therapy Market size was valued at USD 3.1 billion in 2023 and is estimated to grow at a CAGR of 8.2% between 2024 and 2032. The high expansion of the industry can be attributed to several factors such as increasing cases of cancer globally, rising smoking cessation initiatives, growing health awareness & education, and advancements in product development.

 

The growing awareness about the health risks associated with smoking has led to an increased focus on smoking cessation methods. For instance, according to the Centers for Disease Control & Prevention (CDCP), in 2018, out of the 34.2 million people that smoke in U.S., 55% tried smoking cessation. Therefore, government and public health organizations often run anti-smoking campaigns, encouraging people to quit smoking. These campaigns create awareness about the health risks associated with smoking and promote the use of smoking cessation aids like nicotine replacement therapy (NRT).

 

Nicotine Replacement Therapy (NRT) refers to the use of products that contain nicotine as a medical treatment to help people quit smoking. It includes gums, patches, lozenges, inhalers, and nasal spray. The primary goal of NRT is to provide a controlled and safer way for individuals to gradually reduce the nicotine dependence while avoiding the harmful effects of tobacco smoke.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Nicotine replacement therapy industry size was USD 3.1 billion in 2023 and is estimated to reach USD 6.2 billion by 2032 due to the increasing cases of cancer globally, rising smoking cessation initiatives, and the growing health awareness & education

The gums product type segment held 49.7% share of the market in 2023 owing to their ability to manage withdrawal symptoms in a controlled manner.

The oral route of administration segment recorded USD 2.3 billion in revenue in 2023 and will foresee significant expansion between 2024 and 2032 as they are easy to use, allowing individuals to manage cravings in various situations.

North America held 48.4% of the global nicotine replacement therapy market share in 2023 owing to the strong awareness of the health risks associated with smoking in the region

Nicotine Replacement Therapy Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 263
  • Countries covered: 19
  • Pages: 180
 Download Free Sample